Institution of Class Action by Richard Spoor Attorneys TIGER BRANDS LIMITED “Tiger Brands” or “the Company” Incorporated in the Republic of South Africa) Registration number 1944/017881/06) Share code: TBS ISIN: ZAE000071080 Institution of Class Action by Richard Spoor Attorneys; Results of tests carried out on behalf of the National Institute for Communicable Diseases (“NICD”) relating to the presence of Listeria monocytogenes ST6 (“LST6”) Class Action On 29 March 2018, the Company and Enterprise Foods were served with an application issued by Richard Spoor Attorneys for an order declaring the constitution of four classes of claimants who will seek compensation from the Company and Enterprise Foods as a consequence of the involvement of the Company and Enterprise Foods in the listeriosis outbreak. The applicants propose a class action comprising four classes of persons. The first class comprises individuals who contracted listeriosis - but did not die - as a consequence of consuming Enterprise products. The second class comprises individuals who, while in utero, contracted listeriosis - but did not die - as a consequence of their mothers’ consuming Enterprise products. The third class comprises individuals who were dependent upon other individuals who contracted listeriosis and subsequently died as a consequence of consuming Enterprise products. The fourth class comprises individuals who are and/or were responsible for the maintenance of or were in fact maintaining, other individuals who contracted listeriosis from consuming Enterprise products, whether they died as a consequence of the infection or not. The applicants propose to launch the class action in two stages. In the first stage, the applicants will seek a declaratory order establishing the nature and extent of the liability of the Company and Enterprise Foods to the various classes. The second stage, assuming liability is established, will be to determine whether the individual claimants ingested contaminated product, contracted Listeria, and suffered damages. Stage one will proceed on an “opt out” basis; stage two will proceed on an “opt in” basis. It is not possible at this early stage to calculate the damages to which the claimants would be entitled if the liability of the Company and Enterprise Foods is established. Results of tests carried out on behalf of the NICD for the presence of LST6 On Wednesday 28 March 2018, the Department of Health provided the Company with a summary of results of culture identification and whole genome sequencing performed for the NICD based on Listeria monocytogenes isolates, which they indicated were obtained from ready-to-eat products produced by the Company’s Value-Added Meat Products division. LST6 was found in seven of the products. The Company has not had access to the underlying source material analysed on behalf of the NICD nor the details of the tests conducted. At this stage, these results have not been independently verified by the Company. The detailed investigations by the Company continue. Bryanston 29 March 2018 Sponsor J.P. Morgan Equities South Africa Proprietary Limited Date: 29/03/2018 04:43:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.